Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Inflammation × Atorvastatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 5 Prostatic Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Polycystic Ovary Syndrome 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Waldenstrom Macroglobulinemia 1 Venous Thrombosis 1 Rectal Neoplasms 1 Precancerous Conditions 1 Ovarian Neoplasms 1 Ototoxicity 1 Neoplastic Cells, Circulating 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia, Prolymphocytic 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Kidney Neoplasms 1 Inflammation 1 Hodgkin Disease 1 Hemangioma, Cavernous, Central Nervous System 1 Heart Failure 1 Glioblastoma 1 Erectile Dysfunction 1

Interventions

Exercise 5 Vitamin D 2 Tea 2 Sufentanil 2 Spironolactone 2 Oxycodone 2 Omeprazole 2 Metformin 2 Etanercept 2 Colchicine 2 ziprasidone 1 soybean oil, phospholipid emulsion 1 salicylsalicylic acid 1 ginger extract 1 falcarinol 1 falcarindiol 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Tobramycin 1 Sulindac 1 Sodium Salicylate 1 Sevoflurane 1 Sevelamer 1 Rocuronium 1 Riluzole 1 Resistance Training 1 Radiotherapy, Conformal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01821404 2018-05-07

ESTO1

Tampere University Hospital

Phase 2 Completed

Inflammation, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡